Rapamycin dosage    (DrugBank: Rapamycin)

1 disease
IDDisease name (Link within this page)Number of trials
278Huge lymphatic malformation with cervicofacial lesion1

278. Huge lymphatic malformation with cervicofacial lesion    [ 19 clinical trials,   23 drugs,   (DrugBank: 7 drugs),   5 drug target genes,   62 drug target pathways]
Searched query = "Huge lymphatic malformation with cervicofacial lesion", "Huge lymphatic malformation", "Lymphatic malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 19 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03243019
(ClinicalTrials.gov)
June 25, 20181/8/2017Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic MalformationsEvaluation of the Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations of Poor PrognosisLymphatic Malformation;PediatricDrug: rapamycin;Device: MRI;Biological: Rapamycin dosageUniversity Hospital, LilleMinistry of Health, FranceRecruiting1 Year18 YearsAll28Phase 2France